170 related articles for article (PubMed ID: 35881645)
21. Primary cutaneous lymphoma in southern Brazil: a 12-year single-center experience.
Nudelmann LM; Bonamigo RR
Int J Dermatol; 2015 Dec; 54(12):e512-20. PubMed ID: 26496535
[TBL] [Abstract][Full Text] [Related]
22. Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003.
Riou-Gotta MO; Fournier E; Mermet I; Pelletier F; Humbert P; Danzon A; Aubin F
Leuk Lymphoma; 2008 Aug; 49(8):1537-44. PubMed ID: 18766967
[TBL] [Abstract][Full Text] [Related]
23. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
Wobser M; Goebeler M
Pathologe; 2020 Feb; 41(1):79-94. PubMed ID: 31932947
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
25. Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.
Dobos G; de Masson A; Ram-Wolff C; Beylot-Barry M; Pham-Ledard A; Ortonne N; Ingen-Housz-Oro S; Battistella M; d'Incan M; Rouanet J; Franck F; Vignon-Pennamen MD; Franck N; Carlotti A; Boulinguez S; Lamant L; Petrella T; Dalac S; Joly P; Courville P; Rivet J; Dereure O; Amatore F; Taix S; Grange F; Durlach A; Quéreux G; Josselin N; Moulonguet I; Mortier L; Dubois R; Maubec E; Laroche L; Michel L; Templier I; Barete S; Nardin C; Augereau O; Vergier B; Bagot M;
Br J Dermatol; 2021 Jun; 184(6):1059-1067. PubMed ID: 33131055
[TBL] [Abstract][Full Text] [Related]
26. Morbidity and Causes of Death in Patients with Cutaneous T-cell Lymphoma in Finland.
Väkevä L; Lipsanen T; Sintonen H; Ranki A
Acta Derm Venereol; 2017 Jun; 97(6):735-738. PubMed ID: 28175924
[TBL] [Abstract][Full Text] [Related]
27. Clinical roundtable monograph. The management of aggressive T-cell lymphoma: a discussion on transformed mycosis fungoides.
Horwitz SM; Duvic M; Hsi ED
Clin Adv Hematol Oncol; 2010 Dec; 8(12):1-15. PubMed ID: 21344783
[TBL] [Abstract][Full Text] [Related]
28. [Epitheliotropic lymphomas: better identification for improved treatment].
Bagot M
Bull Acad Natl Med; 2010 Oct; 194(7):1365-72. PubMed ID: 22043631
[TBL] [Abstract][Full Text] [Related]
29. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
Olsen EA
Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Willemze R; Hodak E; Zinzani PL; Specht L; Ladetto M;
Ann Oncol; 2013 Oct; 24 Suppl 6():vi149-54. PubMed ID: 23868906
[No Abstract] [Full Text] [Related]
31. Staging and management of cutaneous T-cell lymphoma.
Scarisbrick JJ
Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
[TBL] [Abstract][Full Text] [Related]
32. Multidrug resistance related proteins in primary cutaneous lymphomas.
van Haselen CW; Flens MJ; Scheper RJ; van der Valk P; Scheffer GL; Toonstra J; van Vloten WA
Adv Exp Med Biol; 1999; 457():119-31. PubMed ID: 10500787
[TBL] [Abstract][Full Text] [Related]
33. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
[TBL] [Abstract][Full Text] [Related]
35. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
Acta Derm Venereol; 2011 Sep; 91(5):521-5. PubMed ID: 21547335
[TBL] [Abstract][Full Text] [Related]
36. [Malignant lymphoma of the skin].
Burg G; Dommann S; Dummer R
Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
[TBL] [Abstract][Full Text] [Related]
37. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
Wobser M; Goebeler M
Hautarzt; 2019 Oct; 70(10):815-830. PubMed ID: 31511903
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous lymphomas: single center experience of dermatology and hematology clinics.
Payzin B; Ogretmen Z; Cidem Yildirim A; Ozturk Durur S; Sentekin S
J BUON; 2014; 19(1):171-7. PubMed ID: 24659660
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous lymphomas and COVID-19: What is known so far?
Elmasry MF; Youssef R; Elbendary A; Helmy K; Abdelkader HA
Dermatol Ther; 2021 Jan; 34(1):e14463. PubMed ID: 33112053
[TBL] [Abstract][Full Text] [Related]
40. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
